BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Piribedil

A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.

300+ PubMed studies analyzed · 21 RCTs · Evidence Score: 47.3

Research Domains

Piribedil has been studied across 20 research domains including 🌤️ Mood & Depression, 🧠 Focus & Attention, 🧠 Neuroprotection, 😴 Sleep, 🧠 Memory. The primary research focus is 🌤️ Mood & Depression with 63% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Piribedil, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Nylidrin
12 shared targets
bp
7 shared targets
Dihydroergocornine
8 shared targets
l
8 shared targets
silodosin
9 shared targets
dihydroergocristine
9 shared targets
Cabergoline
11 shared targets
Metoclopramide
12 shared targets
Amisulpride
7 shared targets
mosapride
7 shared targets
Loading evidence profile...

This evidence profile for Piribedil is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.